A collaborative research team has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and predicting patient prognosis. The findings are published in the Journal of Extracellular Vesicles.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗